Pages that link to "Category:CPC C07D401/14"
The following pages link to Category:CPC C07D401/14:
Displaying 50 items.
- RHIZEN PHARMACEUTICALS AG Patent Application Trends in 2024 (← links)
- Principia Biopharma Inc. Patent Application Trends in 2024 (← links)
- TEVA CZECH INDUSTRIES S.R.O Patent Application Trends in 2024 (← links)
- Dana-Farber Cancer Institute, Inc. Patent Application Trends in 2024 (← links)
- ACLARIS THERAPEUTICS, INC. Patent Application Trends in 2024 (← links)
- Athos Therapeutics, Inc. Patent Application Trends in 2024 (← links)
- Revolution Medicines, Inc. Patent Application Trends in 2024 (← links)
- UNIVERSITY OF COPENHAGEN Patent Application Trends in 2024 (← links)
- AstraZeneca AB Patent Application Trends in 2024 (← links)
- BioTheryX, Inc. Patent Application Trends in 2024 (← links)
- Blueprint Medicines Corporation Patent Application Trends in 2024 (← links)
- PFIZER INC. Patent Application Trends in 2024 (← links)
- Nimbus Saturn, Inc. Patent Application Trends in 2024 (← links)
- C4 Therapeutics, Inc. Patent Application Trends in 2024 (← links)
- BRISTOL-MYERS SQUIBB COMPANY Patent Application Trends in 2024 (← links)
- KALVISTA PHARMACEUTICALS LIMITED Patent Application Trends in 2024 (← links)
- Deciphera Pharmaceuticals, LLC Patent Application Trends in 2024 (← links)
- INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS Patent Application Trends in 2024 (← links)
- NANJING NUOYUAN MEDICAL INSTRUMENT CO.LTD Patent Application Trends in 2025 (← links)
- Dana-Farber Cancer Institute, Inc. Patent Application Trends in 2025 (← links)
- THE REGENTS OF THE UNIVERSITY OF MICHIGAN Patent Application Trends in 2025 (← links)
- Boehringer Ingelheim International GmbH Patent Application Trends in 2025 (← links)
- Deciphera Pharmaceuticals, LLC Patent Application Trends in 2025 (← links)
- Northwestern University Patent Application Trends in 2025 (← links)
- The Regents of the University of Michigan Patent Application Trends in 2025 (← links)
- DANA-FARBER CANCER INSTITUTE, INC. Patent Application Trends in 2025 (← links)
- CHIESI FARMACEUTICI S.P.A. Patent Application Trends in 2025 (← links)
- C4 Therapeutics, Inc. Patent Application Trends in 2025 (← links)
- 20250154126. Crys (JIANGSU HENGRUI PHARMACEUTICALS CO., LTD.) (← links)
- 20250154127. Bicyclic (ETERN BIOPHARMA (SHANGHAI) CO., LTD.) (← links)
- 20250163024. Chemical Ta (Dana-Farber Cancer Institute, .) (← links)
- 20250163025. Compounds (Bristol-Myers Squibb) (← links)
- 20250171416. Novel Pyrimidine-2,4-diamine Derivatives, Preparation Method Therefor, Pharmaceutical Composition Containing Same As Active Ingredient Pr (KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY) (← links)
- 20250171417. Heteroc (Xizang Haisco Pharmaceutical ., .) (← links)
- 20250171418. Parp1 Inhibitors Uses There (XinThera, .) (← links)
- 20250171419. Novel Nicotina (Heidelberg Pharma Research) (← links)
- 20250171420. Molecular Glue D (Monte Rosa Therapeutics, .) (← links)
- 20250188056. Cereblon Binding Compounds (Celgene) (← links)
- 20250188057. Non-aromatic Cyclic-py (Merck Sharp & Dohme LLC) (← links)
- 20250188058. New Forms N-(5-((6,7-dime (QURIENT ., .) (← links)
- 20250188059. Novel Compound Use T (ARUM THERAPEUTICS) (← links)
- 20250206717. Compound Havin (Innovstone Therapeutics Limited) (← links)
- 20250206718. Nitrogen- (SHANGHAI HANSOH BIOMEDICAL ., .) (← links)
- 20250206719. Albicidin Deriv (TECHNISCHE UNIVERSITÄT BERLIN) (← links)
- 20250206720. Solid Forms (Deciphera Pharmaceuticals, LLC) (← links)
- 20250206721. Prostaglandin Receptor Ep2 (EMORY UNIVERSITY) (← links)
- 20250214965. Compound As (Hangzhou Innogate Pharma ., .) (← links)
- 20250214966. Crystalline Salt Form (Array BioPharma .) (← links)
- 20250214967. Fak Degraders, Pha (Berrybio (Shanghai) Limited) (← links)
- 20250214968. Novel Salt (Ildong Pharmaceutical ., .) (← links)